Quest Diagnostics
643 hedge funds and large institutions have $13.4B invested in Quest Diagnostics in 2017 Q2 according to their latest regulatory filings, with 73 funds opening new positions, 203 increasing their positions, 232 reducing their positions, and 41 closing their positions.
167% more funds holding in top 10
Funds holding in top 10: 3 → 8 (+5)
78% more first-time investments, than exits
New positions opened: 73 | Existing positions closed: 41
38% more call options, than puts
Call options by funds: $24M | Put options by funds: $17.4M
11% more capital invested
Capital invested by funds: $12.1B → $13.4B (+$1.33B)
5% more funds holding
Funds holding: 614 → 643 (+29)
1.31% less ownership
Funds ownership: 89.35% → 88.04% (-1.3%)
13% less repeat investments, than reductions
Existing positions increased: 203 | Existing positions reduced: 232
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$152M |
| 2 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
+$131M |
| 3 |
Robeco Institutional Asset Management
Rotterdam,
Netherlands
|
+$84.1M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$55.5M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
+$52.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Schroder Investment Management Group
London,
United Kingdom
|
-$170M |
| 2 |
LSV Asset Management
Chicago,
Illinois
|
-$163M |
| 3 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$114M |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$61.7M |
| 5 |
Bessemer Group
Woodbridge,
New Jersey
|
-$52.7M |
DGX Hedge Fund Activity: Q2 2017 in Review
643 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Quest Diagnostics (DGX) for Q2 2017, worth a combined $13.4B — up 11% from $12.1B a quarter earlier.
Buyers outnumbered sellers: 73 funds opened new DGX positions and 41 closed out — a net gain of 32 holders — while 203 added to existing stakes and 232 trimmed.
The largest buyer was Janus Henderson Group, adding an estimated $152M. The largest seller was Schroder Investment Management Group, cutting an estimated $170M.
- 643 institutional investors held Quest Diagnostics (DGX) as of Q2 2017, up from 614 in Q1 2017.
- Funds reported $13.4B of Quest Diagnostics stock for Q2 2017, up 11% quarter-over-quarter.
- 73 funds opened new Quest Diagnostics positions in Q2 2017 and 41 closed out, a net change of +32 holders.
- The largest Quest Diagnostics buyer in Q2 2017 was Janus Henderson Group, an estimated $152M added.
- The largest Quest Diagnostics seller in Q2 2017 was Schroder Investment Management Group, an estimated $170M sold.
Based on aggregated 13F filings for Q2 2017.